JP2023522990A5 - - Google Patents
Info
- Publication number
- JP2023522990A5 JP2023522990A5 JP2022564281A JP2022564281A JP2023522990A5 JP 2023522990 A5 JP2023522990 A5 JP 2023522990A5 JP 2022564281 A JP2022564281 A JP 2022564281A JP 2022564281 A JP2022564281 A JP 2022564281A JP 2023522990 A5 JP2023522990 A5 JP 2023522990A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- formula
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025104709A JP2025134881A (ja) | 2020-04-23 | 2025-06-20 | Ｓａｒｓの治療のための化合物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063014501P | 2020-04-23 | 2020-04-23 | |
| US63/014,501 | 2020-04-23 | ||
| US202063120079P | 2020-12-01 | 2020-12-01 | |
| US63/120,079 | 2020-12-01 | ||
| PCT/US2021/019285 WO2021216195A1 (en) | 2020-04-23 | 2021-02-23 | Compounds for the treatment of sars |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025104709A Division JP2025134881A (ja) | 2020-04-23 | 2025-06-20 | Ｓａｒｓの治療のための化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023522990A JP2023522990A (ja) | 2023-06-01 |
| JP2023522990A5 true JP2023522990A5 (enExample) | 2024-02-14 |
Family
ID=78269813
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022564281A Pending JP2023522990A (ja) | 2020-04-23 | 2021-02-23 | Ｓａｒｓの治療のための化合物 |
| JP2025104709A Pending JP2025134881A (ja) | 2020-04-23 | 2025-06-20 | Ｓａｒｓの治療のための化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025104709A Pending JP2025134881A (ja) | 2020-04-23 | 2025-06-20 | Ｓａｒｓの治療のための化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230159516A1 (enExample) |
| EP (1) | EP4139280A4 (enExample) |
| JP (2) | JP2023522990A (enExample) |
| KR (1) | KR20230005240A (enExample) |
| CN (1) | CN115667209A (enExample) |
| AU (1) | AU2021259145A1 (enExample) |
| BR (1) | BR112022021381A2 (enExample) |
| CA (1) | CA3176370A1 (enExample) |
| MX (1) | MX2022013081A (enExample) |
| WO (1) | WO2021216195A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11124497B1 (en) | 2020-04-17 | 2021-09-21 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| US11174231B1 (en) | 2020-06-09 | 2021-11-16 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| JP2024102382A (ja) * | 2021-05-18 | 2024-07-31 | 国立研究開発法人国立国際医療研究センター | 抗ウイルス活性等の生理活性を有する化合物 |
| WO2022256434A1 (en) * | 2021-06-02 | 2022-12-08 | ACEA Therapeutics, Inc. | Protease inhibitors as antivirals |
| US20230033285A1 (en) * | 2021-06-16 | 2023-02-02 | The Scripps Research Institute | Protease Inhibitors for Treatment of Coronavirus Infections |
| CN114456211B (zh) * | 2021-09-03 | 2024-03-26 | 中国药科大学 | 一种拟肽类化合物及其制备方法和应用 |
| CN115806570B (zh) * | 2021-11-15 | 2023-09-12 | 南京知和医药科技有限公司 | 一种拟肽衍生物及其药物组合物和用途 |
| KR20250109233A (ko) * | 2022-11-22 | 2025-07-16 | 머크 샤프 앤드 돔 엘엘씨 | 코로나바이러스 감염을 치료 또는 예방하기 위한 프로테아제 억제제로서의 2-아미노-n-(4-아미노-3,4-디옥소-1-(2-옥소피롤리딘-3-일)부탄-2-일)벤즈아미드 유도체 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3507486B2 (ja) | 1991-03-15 | 2004-03-15 | アムジエン・インコーポレーテツド | 顆粒球コロニー刺激因子の肺内投与 |
| US5451569A (en) | 1994-04-19 | 1995-09-19 | Hong Kong University Of Science And Technology R & D Corporation Limited | Pulmonary drug delivery system |
| PA8507801A1 (es) * | 1999-12-03 | 2002-08-26 | Agouron Pharma | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis |
| WO2004093860A1 (en) * | 2003-04-21 | 2004-11-04 | Pfizer Inc. | Inhibitors of sars related coronavirus proteinase |
| EP1704142A4 (en) * | 2003-12-31 | 2008-08-20 | Taigen Biotechnology Co Ltd | PROTEASE INHIBITORS |
| WO2006061714A2 (en) * | 2004-12-09 | 2006-06-15 | Pfizer Inc. | Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis |
| US20110269834A1 (en) * | 2008-08-21 | 2011-11-03 | The Board Of Trustees Of The University Of Illinois | Compounds and methods for treating respiratory diseases |
| EP2718261B1 (en) * | 2011-06-08 | 2016-02-24 | Nitto Denko Corporation | Compounds for targeting drug delivery and enhancing sirna activity |
| CN102838523A (zh) * | 2011-06-23 | 2012-12-26 | 南开大学 | 抗肠病毒71(ev71)戊内酰胺类化合物及其制备方法和用途 |
| CA2850003C (en) * | 2011-09-27 | 2020-01-07 | Kansas State University Research Foundation | Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses |
| CN103130710B (zh) * | 2011-11-29 | 2015-12-16 | 南开大学 | 抗肠病毒71(ev71)己内酰胺醛类化合物及其制备方法和用途 |
| CN106928206B (zh) * | 2015-12-31 | 2022-02-18 | 中国科学院上海药物研究所 | 醛基类化合物及其制法和用途 |
| CN110818691A (zh) * | 2018-08-09 | 2020-02-21 | 中国科学院上海药物研究所 | 酮酰胺类化合物及其制备方法、药物组合物和用途 |
| BR112021023814A2 (pt) * | 2020-06-09 | 2022-12-20 | Pardes Biosciences Inc | Inibidores de proteases de cisteína e métodos de uso das mesmas |
-
2021
- 2021-02-23 BR BR112022021381A patent/BR112022021381A2/pt unknown
- 2021-02-23 US US17/996,898 patent/US20230159516A1/en active Pending
- 2021-02-23 CA CA3176370A patent/CA3176370A1/en active Pending
- 2021-02-23 WO PCT/US2021/019285 patent/WO2021216195A1/en not_active Ceased
- 2021-02-23 AU AU2021259145A patent/AU2021259145A1/en active Pending
- 2021-02-23 MX MX2022013081A patent/MX2022013081A/es unknown
- 2021-02-23 KR KR1020227040414A patent/KR20230005240A/ko active Pending
- 2021-02-23 EP EP21793587.3A patent/EP4139280A4/en active Pending
- 2021-02-23 JP JP2022564281A patent/JP2023522990A/ja active Pending
- 2021-02-23 CN CN202180029527.5A patent/CN115667209A/zh active Pending
-
2025
- 2025-06-20 JP JP2025104709A patent/JP2025134881A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023522990A5 (enExample) | ||
| ES2266422T3 (es) | Derivados de alfa-aminoacidos, su procedimiento de preparacion y su utilizacion como inhibidores de la dipeptidil-peptidasa iv (dpp iv). | |
| JP2020169171A5 (enExample) | ||
| JP2023521116A5 (enExample) | ||
| RU2003110577A (ru) | Гетероциклические соединения, связывающиеся с хемокиновыми рецепторами | |
| JP2017518959A5 (enExample) | ||
| RU2020108523A (ru) | Гетероарил-замещенные бета-гидроксиэтиламины для применения для лечения гипергликемии | |
| AR064212A1 (es) | Uso de profarmacos de analogos de gaba para tratar enfermedades | |
| JP2009519243A5 (enExample) | ||
| JP2024522174A5 (enExample) | ||
| DE4004820A1 (de) | Renininhibitoren, verfahren zur herstellung und ihre verwendung in arzneimitteln | |
| RU2006134003A (ru) | Серосодержащие соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с | |
| JP2020507589A5 (enExample) | ||
| JP2022095872A5 (enExample) | ||
| JP2010527913A5 (enExample) | ||
| JP2005514420A5 (enExample) | ||
| JP2013540776A5 (enExample) | ||
| JP2023504542A5 (enExample) | ||
| JPWO2008099874A1 (ja) | ピラジン誘導体を含有する医薬組成物およびピラジン誘導体を組み合わせて使用する方法 | |
| TW200512184A (en) | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure | |
| JP2019519616A5 (enExample) | ||
| RU2007106935A (ru) | Производные гуанидина и их терапевтическое применение | |
| FI78300C (fi) | Foerfarande foer framstaellning av farmakologiskt verkande fosfatidylfoereningar. | |
| KR910018363A (ko) | 3,5-이치환된 2-이소옥사졸린 및 이소옥사졸, 이의 제조방법 이를 함유하는 약제 및 이의 용도 | |
| JP2021521178A5 (enExample) |